These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A2 antagonist, on human, guinea pig and rat platelets. Miki I, Kishibayashi N, Nonaka H, Ohshima E, Takami H, Obase H, Ishii A. Jpn J Pharmacol; 1992 Jul; 59(3):357-64. PubMed ID: 1434130 [Abstract] [Full Text] [Related]
27. Thromboxane A2 and vascular smooth muscle cell proliferation. Sachinidis A, Flesch M, Ko Y, Schrör K, Böhm M, Düsing R, Vetter H. Hypertension; 1995 Nov; 26(5):771-80. PubMed ID: 7591017 [Abstract] [Full Text] [Related]
32. Comparison of vascular and platelet thromboxane A2/prostaglandin H2 receptors in the pig. Mihara S, Hara S, Ueda M, Ide M, Fujimoto M. Eur J Pharmacol; 1989 Feb 07; 160(3):313-21. PubMed ID: 2523812 [Abstract] [Full Text] [Related]
33. Renal vascular responsiveness to arachidonic acid in experimental diabetes. Quilley J, McGiff JC. Br J Pharmacol; 1990 Jun 07; 100(2):336-40. PubMed ID: 2116203 [Abstract] [Full Text] [Related]
34. Peroxide induces vasoconstriction in the human placenta by stimulating thromboxane. Walsh SW, Wang Y, Jesse R. Am J Obstet Gynecol; 1993 Oct 07; 169(4):1007-12. PubMed ID: 8238110 [Abstract] [Full Text] [Related]
35. Impaired vasocontractile responses to adenosine in chorionic vessels of human term placenta from pregnant women with pre-existing and gestational diabetes. Razak AA, Leach L, Ralevic V. Diab Vasc Dis Res; 2018 Nov 07; 15(6):528-540. PubMed ID: 30130976 [Abstract] [Full Text] [Related]
36. Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers. Uematsu T, Kosuge K, Umemura K, Nakano M, Terakawa M, Nakashima M. J Pharm Pharmacol; 1996 Apr 07; 48(4):380-5. PubMed ID: 8794987 [Abstract] [Full Text] [Related]
37. Thromboxane A2 receptor stimulation similarly potentiates pressor responses to 5-hydroxytryptamine in perfused hindquarters of non-diabetic and alloxan diabetic rats. Sikorski BW, Hodgson WC, King RG. Clin Exp Pharmacol Physiol; 1991 Apr 07; 18(4):237-44. PubMed ID: 1829992 [Abstract] [Full Text] [Related]
38. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors. Naka M, Mais DE, Morinelli TA, Hamanaka N, Oatis JE, Halushka PV. J Pharmacol Exp Ther; 1992 Aug 07; 262(2):632-7. PubMed ID: 1386885 [Abstract] [Full Text] [Related]
39. Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed. McMahon TJ, Hood JS, Nossaman BD, Ibrahim IN, Feng CJ, Kadowitz PJ. J Appl Physiol (1985); 1991 Nov 07; 71(5):2012-8. PubMed ID: 1837015 [Abstract] [Full Text] [Related]
40. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. Yin K, Halushka PV, Yan YT, Wong PY. J Pharmacol Exp Ther; 1994 Sep 07; 270(3):1192-6. PubMed ID: 7932171 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]